¾ÅÖÝÓ°Ôº

Introduction

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of over 30 speakers will present a full conference programme covering the topics outlined below.

Advances in Immuno-oncology Congress
Day 1 Stream 1 – Discovery and Early Development of Immuno-oncology Therapies

• Key therapeutic strategies in immuno-oncology

– Checkpoint inhibitors
– CAR T cell therapies
– Adoptive cell transfer
– Cancer vaccines & oncolytic viral therapies
– Immune receptor agonist antibodies
– BiTe (Bispecific T Cell Engagers)

• Targeting the PD-1 pathway and finding alternative therapeutic targets
• Novel technologies to enhance discovery of immunotherapies in oncology
• Molecular oncology updates including B cells

Day 1 Stream 2 – Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials

• Approaches to clinical trial design & development
• Key safety challenges in cancer immunotherapy clinical trials
• Strategies for effective trial management
• Clinical data & case studies
• Clinical immuno-oncology combinations in different cancers and tumour types
• Establishing partnerships and collaborations
• Biomarkers in immuno-oncology
• Clinical diagnostics & the potential of NGS in immuno-oncology clinical trials

Day 2– Preclinical Development, Assays and Modelling in Immuno-oncology

• Preclinical models including humanised mouse models
• Preclinical assay development
• Translational strategies
• Approaches to preclinical combination therapy design
• Reducing toxicity challenges in immuno-oncology therapeutics
• Innovative technologies for immunotherapy

Speakers

• http://www.immunooncology-congress.com/who-is-speaking/ United Kingdom

---

Venue

TBA, Central London

TBA, Central London, TBA, Central London, London, W1, United Kingdom

Organised by

Oxford Global

Contact information

Danielle Dalby
01865248455
Contact us by email

---